Rising obesity and chronic disease are making ultrasound exams more complex, leading to higher rates of inconclusive results and creating demand for advanced imaging technologies that provide deeper penetration, intelligent clinician support and diagnostic consistency. At the same time, widespread sonographer pain and workforce shortages highlight the importance of ergonomic design. The R20 was designed to meet these challenges head-on, combining imaging precision, Artificial Intelligence (AI) and ergonomics in a single system.

Built for exceptional imaging performance, the R20 is powered by Samsung’s Advanced Imaging Engine: integrating cutting-edge hardware with sophisticated software beamforming to achieve remarkable image clarity and diagnostic accuracy. R20 offers more than a dozen AI-powered tools¹ for real-time exam guidance, diagnostic assistance, workflow automation and automated measurements to help clinicians improve accuracy, save time and scan with greater confidence in complex cases. Complementing its clinical performance, the R20 achieved independent validation as a leader in ergonomic innovation, meeting 100% of recognized ergonomic guidelines and recommendations² to promote clinician comfort and healthy scanning.

“The R20 embodies our mission to elevate diagnostic imaging through purposeful innovation,” said Tracy Bury, Chief Commercial Officer of Samsung Healthcare in the USA and Vice President of Global Growth Initiatives. “Driven by close collaboration with clinicians, the R20’s technologies are designed as practical tools that make a real difference in how clinicians work and patients are cared for. With the R20, we’re moving from a fast follower to a true technology leader, driving innovation at a pace that’s reshaping ultrasound.”

The Samsung R20 will be unveiled in the U.S. for the first time at the Radiological Society of North America (RSNA) 2025 Annual Meeting on Sunday, November 30, 2025 from 11:00–11:15 a.m. at the Samsung booth #6122 in North Hall B.

Attendees are invited to experience the R20 firsthand and explore how Samsung is redefining ultrasound performance through innovation in imaging, AI and ergonomics. For more information about the Samsung R20, visit: https://usa.samsunghealthcare.com/ultrasound/general-imaging/r20.

1. Data on file. Product features and availability may vary by region due to local regulatory requirements. ︎
2. Whitepaper. Sound Ergonomics. Samsung R20 Ergonomic Evaluation. 2025 ︎

Samsung Electronics Health and Medical Equipment Business and Samsung Medison participated in the 2024 Radiological Society of North America (RSNA) conference in Chicago, United States, from December 1st to 5th (local time) and unveiling an even more diverse product lineup.

To strengthen its competitiveness across medical specialties, after the launch of a new OB & GYN ultrasound diagnostic system, HERA Z20, Samsung proposed ‘pediatric integrated solution’ encompassing the entire range of its medical diagnostic devices through this RSNA.

In the ‘Ultrasound Zone,’ a dedicated probe for the pediatric cardiac diagnosis ‘TA2-9’ was unveiled for the first time at this exhibition. The TA2-9 with 42% smaller head than adult echocardiography probe aids in more accurate diagnosis for congenital heart disease or functional and structural abnormalities of heart through the oral route. Also on display was ‘L3-22’, a dedicated neonatal probe featuring a smaller head compared to an adult version offering a wide frequency range which enables pediatric body scan with a single device without the need to switch probes.

All US Food and Drug Administration (FDA) 510(k) cleared products of Samsung digital X-ray have ‘low dose’ capability making it more appropriate for diagnosis of children and adolescents where safety is particularly prioritized. Samsung’s proprietary S-Vue imaging engine reduces radiation exposure by up to 50% compared to systems without this technology.

At this exhibition, Samsung launched a new ‘floor-mounted’ digital X-ray, GF 85. The new digital X-ray, GF 85 launched by Samsung is relatively affordable compared to ceiling-mounted type and cost-effective with the ability to be installed in a small space without ceiling construction. Moreover, it provides clear image quality even with low dose and is equipped with advanced AI diagnostic assistance feature, fully inheriting all the advantages of previous digital X-ray models.

NeuroLogica Corp, a subsidiary of Samsung Electronics, includes the OmniTom Elite mobile computed tomography (CT) in its portfolio, useful for imaging pediatric patients and at point-of-care, facilitating rapid clinical decision making and reducing transport related risks. Mobile CT is already recognized for its utility, with 8 out of the top 10 U.S. pediatric hospitals (as ranked by U.S. News for 2024-2025) utilizing the technology.

NeuroLogica’s OmniTom Elite with photon counting detector (PCD) technology showcased this year’s at RSNA delivers ultra high-resolution CT imaging at the point-of-care using FDA 510(k) cleared PCD technology, surpassing conventional CT methods that rely on energy integrating detectors. By utilizing photon counting detectors to measure the energy of each individual photon, this cutting-edge technology enhances contrast differentiation and virtual monoenergetic imaging, empowering radiologists with greater confidence in diagnosing patients.

Samsung provides opportunity to gain clinical application tips of Samsung medical devices and engage in Q&A with the global experts through Lunch & Learn session. In this session, a global breast imaging expert, Dr. Nina Vincoff shared a screening program using Samsung breast ultrasound solution and the latest insights on the FDA’s mandate for breast density information provision and implementation of additional imaging examination recommendation for dense breast (effective on September 10, 2024).

Dr. Farhad Farzanegan in Kasier Permanente South Sacramento health system U.S. presented a case study on hospital workflow improvement based on the result of CT intervention procedure using Samsung mobile full-body CT, BodyTom.

In the booth, Dr. Jon Jacobson, a musculoskeletal radiology expert, conducted live scan using a premium ultrasound diagnostic device, RS85 Prestige introducing clearer image quality and more sophisticated AI diagnostic assistance feature.

The leader of the Samsung Medison AI&Informatics group, Vijay, said “I discovered a greater potential through high praises from medical professors around the world who visited the site” and “Moving forward, we aim to further enhance our AI diagnostic support features tailored to specialized medical fields, solidify our technological leadership in radiology and obstetrics, and expand our competitiveness across all medical disciplines to pioneer new markets.”

▲ The high-tech, yet highly mobile OmniTom Elite with Photon Counting Detector (PCD) CT scanner is designed to offer advanced imaging at the point-of-care.

NeuroLogica Corp., a subsidiary of Samsung Electronics and a pioneer in premium diagnostic imaging solutions, will showcase its latest offerings in mobile computed tomography (CT) and feature the OmniTom^® Elite Photon Counting mobile CT scanner at the Radiological Society of North America (RSNA) Annual Meeting in Chicago from November 26 to November 30.

The clinical launch of the OmniTom Elite Photon Counting mobile CT scanner, a single-source photon counting computed tomography scanner utilizing NeuroLogica’s proprietary detector technology (PCD), will be featured at this year’s meeting. Photon counting is a next-generation CT technology that sorts the different energies of X-rays after they have passed through the scan field, capturing the X-ray photons directly at the detector and converting the energy to electrical signals.

The OmniTom Elite’s ability to provide versatile, real-time mobile imaging enables healthcare providers to administer point-of-care CT to critical patients without the need to transport them to a separate department, expanding the diagnostic possibilities of CT at the patient’s bedside.

“The OmniTom Elite is an advanced imaging solution that is extremely mobile, giving healthcare providers more flexibility in when and where they run diagnostic tests for their patients,” said Renaud Maloberti, Vice President, Head of Business, MCT. “We look forward to featuring this innovative technology at this year’s Radiological Society of North America Annual Meeting.”

NeuroLogica will showcase its innovation at Booth #6133, McCormick Place, and unveil the OmniTom Elite with PCD on Sunday, November 26 at 10:30 am CST, with a live demonstration of this state-of-the-art technology.

Also on Sunday, November 26 from 11:45 am to 12:45 pm CST in the South Building, Level 4, Room S403B, McCormick Place, Dr. Raj Gupta of Massachusetts General Hospital and Professor Iris Grunwald of the University of Dundee host the Samsung NeuroLogica Lunch & Learn Event “Photon Counting: The Next Generation of Neuro CT.” They will discuss how leveraging the latest innovation in CT applications may increase productivity and enhance the patient and physician experience.

For more information or to register, visit www.eventcreate.com/e/samsungrsna2023.

▲ Samsung will showcase its premium diagnostic imaging solutions in ultrasound, digital radiography and mobile computed tomography at the Radiological Society of North America (RSNA) 108th Scientific Assembly and Annual Meeting.

Samsung Electronics will be unveiling its latest artificial intelligence (AI) technologies and presenting its premium diagnostic solutions in ultrasound, digital radiography (DR) and mobile computed tomography (CT) at the Radiological Society of North America (RSNA) 108th Scientific Assembly and Annual Meeting from November 27 to December 1.

David Legg, Vice President, Head of Business, Boston Imaging, a subsidiary of Samsung, shares, “Samsung has a long-standing history of leading the charge in technology advancements – 2022 has been a testament to this as we have worked to redefine our cutting-edge solutions across modalities. We’re now deploying real-time on-device AI technology to help healthcare professionals examine and diagnose patients with ease and accuracy from the start.”

Samsung has remained focused on the critical clinical needs that elevate customer experience when developing new products. During the conference, the company will highlight 2022 achievements that worked to make the world a healthier place by empowering clinicians to diagnose their patients more confidently.

“Innovation is at the core of Samsung’s business. We take great pride in delivering our customers’ leading-edge technology on all Samsung devices,” said Kyu Tae Yoo, Senior Vice President, Global Head of Sales and Marketing, Samsung Medison. “As we look to expand diagnostic possibilities and improve the clinical experience that our customers need, we will keep healthcare professionals and the patients they treat top of mind.”

Additional details about the novel innovations Samsung will showcase during the conference can be found below.

Ultrasound

At the event, Samsung will showcase leading product updates, including the V7 ultrasound system, a new endocavity transducer and new real-time on-device AI solutions.

The new on-device AI solution for ultrasound, known as HeartAssist, which can enhance the diagnosis and examination process, will be on display. It’s a deep learning-based function that automatically finds the cross-section of the heart and measures different points needed for an accurate diagnosis. The automated nature allows for a streamlined workflow due to fewer keystrokes. The feature can be found on the V8 and V7 ultrasound systems.

Samsung also recently released the new V7 ultrasound system, which provides a wide array of clinical applications, including a range of on-device Intelligent Assist features such as BiometryAssist and UterineAssist, that enhance both the patient and user experience.

From general imaging to women’s health, it was designed to deliver a multi-faceted diagnostic experience. Crystal Architecture is the core of the V7’s enhanced image clarity and penetration and is built upon the combination of innovative beamforming (CrystalBeam), sophisticated image processing (CrystalLive) and advanced S-Vue Single Crystal Transducers to produce clear, uniform and high-resolution images.

The miniER7,¹ a new endocavity transducer, will be shown alongside the V7 ultrasound system. With a radius size of 7mm — 3mm smaller than the existing probe — the new probe was designed to ease the burden felt by healthcare professionals as well as the discomfort that patients often experience during prostate ultrasound scanning. The miniER7 was created with state-of-the-art micro-processing technology to capture clear images at a reduced file size.

Digital Radiography

Samsung is also showcasing its premium digital radiography solutions, including the new “Vision Assist” solution and AccE Glass Free Detector.

The AccE GC85A Vision² premium ceiling digital radiography system with “Vision Assist” provides more enhanced patient care and workflow efficiency maintaining an advanced low-dose imaging experience. Specifically, the AccE GC85A Vision focuses on new ways to increase efficiencies so healthcare professionals can streamline without compromising, including:

• Reduced Operation Time: The Intelligent Collimation and Stitching Auto Planning features provide the optimal collimated area automatically with just one click using deep learning technology. While the Patient Size Guide recommends patient size and optimal parameters based on the patient’s body thickness to save time.³
• Decreased Retake Error: The Virtual Overlay feature displays a virtual drawing of the receptor boundary and AEC chamber onto the patient to help the operator with patient positioning. The Motion Alarm based on machine learning technology can inform the operator of patient movements and falls. Virtual Collimation then allows the operator to make adjustments to the collimated area from the control room with ease.³
• Continuous Patient Care: The operator can continuously monitor the patient through Vision Live, which is a live camera in the tube head unit.

With a strategic focus on workflow optimization, Samsung also recently released a new flagship detector, the AccE Glass-Free Detector, which offers a more comfortable imaging experience without compromising image quality. Designed to deliver high-resolution images of a lightweight digital detector, it provides additional user and patient benefits, including:

• Functionality: It boasts a non-glass flexible panel with center-engraving to position a patient, a side chamfer to ease lifting and a rear grip to support transportation. It also weighs 27% lighter than the conventional model⁴ (approximately 4.5 pounds).⁵
• Reliability: Its high load allowance (up to 881 pounds of surface load and 441 pounds of patient load)⁶ and dust and water-resistant design allows for reduced user concern in complex environments like the ER and OR.
• Clear Visibility: It exhibits a 76% DQE, leading the market in glassless panel technology.

Computed Tomography

Also featured at RSNA is the OmniTom^® Elite with Photon Counting Detector (PCD) technology and BodyTom^® 64.

The state-of-the-art OmniTom^® Elite has the ability to provide versatile, real-time mobile imaging to administer point-of-care CT to critical patients without the need to transport them to a separate imaging department. With the addition of PCD technology, the system provides the ability to capture CT data in multiple energy bands. The multiple sets of CT data are acquired at the same time with configurable energy thresholds without any cross talk between images. The PCD system⁷ brings multi-energy CT functionality with spectral capability for material decomposition, virtual monoenergetic images (VMI) and soft tissue identification.

The BodyTom^® 64 is an upgraded version of the BodyTom^® Elite CT scanner, providing enhanced functionality with high-resolution imaging capabilities. The head-to-toe trauma imaging solution boasts revisions based on customer feedback, with indications for both pediatric and adult imaging and can be used for low dose lung cancer screening. The BodyTom^® 64 is a multi-departmental imaging solution that can be utilized in neurosurgery, interventional radiology, brachytherapy, trauma, medical examination and more.

Environmental, Social and Governance

Samsung not only focuses on advancing its diagnostic solutions and technologies, but also takes part in protecting the environment by developing eco-friendly packages as a part of its environmental, social and governance management.

Expanded Polyethylene foam (EPE) foams that were previously used in the ultrasound packages were replaced by recycled papers, resulting in the reduction of 15 tons of EPE foams in 2022. Samsung’s goal is “Zero” usage of EPE foams by 2023. In addition, polyurethane materials that were used for transducer packages are also being replaced by recycled papers, expecting to reduce the usage of polyurethane to 8 tons.

Visit Samsung at Booth # 2165. To learn more about the Samsung products on display and other events visit: https://samsunghealthcare.com/en/rsna2022.

About Boston Imaging

Boston Imaging markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. Boston Imaging is the United States headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. Boston Imaging’s growing portfolio of advanced medical technologies is used in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction and increase workflow efficiency. For more information, please visit https://www.bostonimaging.com/.

About NeuroLogica

NeuroLogica Corp., the healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. NeuroLogica is the global corporate headquarters and manufacturer of mobile computed tomography devices. NeuroLogica’s growing portfolio of advanced medical technologies are used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. For more information, please visit: http://www.neurologica.com.

¹ miniER7: Pending FDA 510(k) clearance, not available for sale within the United States

² The AccE GC85A Vision is a sub configuration of The AccE GC85A

³ Compared to the current AccE GC85A configuration, without a camera solution

⁴ Compared to S4335-AW

⁵ Measured without battery set

⁶ Based on 40 mm diameter disc at the center

⁷ OmniTom^® Elite with PCD: Pending FDA 510(k) clearance, not available for sale within the United States

“This has been a momentous year for Samsung. We have worked to advance our solutions by leveraging high computing power and artificial intelligence (AI) technologies,” said David Legg, Vice President, Digital Radiography and Ultrasound, NeuroLogica. “We will be deploying AI features in each of our products to provide benefits to healthcare professionals and patients alike.”

Ultrasound

At the event, Samsung will showcase its new V8, which is a premium ultrasound system that provides enhanced image quality, usability and convenience for ultrasound professionals. Crystal Architecture is the core of the V8’s image clarity and penetration and is built upon the combination of innovative beamforming (CrystalBeam), sophisticated image processing (CrystalLive) and advanced S-Vue Single Crystal Transducers to produce clear, uniform and high-resolution images.

The feature-packed device includes two new AI functions, one being NerveTrack, which detects nerves and provides nerve location information in real-time to anesthesiologists and expert practitioners. The function is designed to provide users with accurate nerve detection, faster image processing and better workflow support. The second AI function is UterineAssist, which detects tissue changes and assists the user in taking measurements of the uterus. With these and other new tools, the V8 delivers a new level of versatility and value to a wide range of diagnostic medical ultrasound departments.

Samsung has also worked to advance its ultrasound solutions for women’s health. Recently, the Hera W9 and W10 received Food and Drug Administration (FDA) 510(K) clearance for its new AI functions, which gives the operator the ability to measure anatomical structures and analyze imaging, providing useful information to aid diagnosis.

New features include:

• HeartAssist: A deep learning-based function that provides classification of ultrasound images to display measurements. The feature recognizes various views and proposes caliper placements and corresponding measurements allowing users to save time with measurement proposals and increase examination efficiency by reducing keystrokes.
• ViewAssist: A deep learning-based function that classifies ultrasound images to deliver key scanning views and provides annotations. The feature recognizes a range of views, proposes corresponding anatomy annotations and initiates measurements.
• BiometryAssist: An automatic solution for biometric measurement that can be modified by the user. It enables users to measure fetal growth parameters with one click while maintaining exam consistency.

Digital Radiography

Samsung is also showcasing its premium digital mobile X-ray, the AccE GM85, which delivers unparalleled performance and gives users better diagnostic confidence while improving workflow. Recently, Samsung received FDA 510(k) clearance for its Auto Lung Nodule Detection (ALND) tool, which can be utilized in the AccE GC85A and in other systems. The ALND is provided as an on-device computer-assisted detection (CADe) software that uses an AI algorithm to detect pulmonary nodules between 10 and 30mm in size.¹

The benefits of ALND include:

• Aids the user in the diagnostic process by indicating the location of suspected lung nodules on chest X-ray images (posteroanterior chest radiographs).
• Offers the option (Autorun) to automatically perform nodule detection immediately after chest X-ray imaging in addition to PACS transmission options to suit the hospital environment, both of which simplify the user’s workflow.
• The ALND has been clinically verified by multiple university hospitals and has been approved with a sensitivity of 80% or more.² As part of Samsung’s commitment to advancing diagnostic radiology using AI, Samsung will expand the uses of the chest CADe solution and continue improving diagnostic accuracy and workflow.

Computed Tomography

Also featured at RSNA is the OmniTom^® Elite – a mobile computed tomography (CT) scanner that delivers high-quality non-contrast CT, CT angiography and CT perfusion scans at point-of-care. The OmniTom Elite CT boasts a small footprint and high-resolution image quality. The advancements of the scanner help to optimize diagnostic confidence, speed and workflow across departments, such as neurosurgery, pediatric imaging, critical care, diagnostic radiology and more.

Earlier this year, NeuroLogica announced that the OmniTom Elite with Photon Counting Detector (PCD) technology will be piloted by Massachusetts General Hospital, bringing CT imaging to the patient’s point-of-care. Pending FDA 510(k) clearance, the hospital is testing the OmniTom Elite with PCD to monitor post-trauma and post-surgical patients.

The OmniTom Elite’s ability to provide versatile, real-time mobile imaging enables healthcare providers to administer point-of-care CT to critical patients without the need to transport them to a separate department. The mobile unit will decrease the time it takes to diagnose and initiate treatment for patients in the ICU. During the pilot stage for the OmniTom Elite with PCD, Massachusetts General Hospital will guide best practices and evaluate use cases for the novel system.

Visit Samsung at Booth #6952.

Samsung will showcase its premium diagnostic imaging solutions in ultrasound, digital radiography and mobile computed tomography at the Radiological Society of North America (RSNA) 2021 Annual Meeting.

About Samsung Medison Co., Ltd.

Samsung Medison is a global leading medical device company, founded in 1985. With a mission to bring health and well-being of people’s lives, the company manufactures diagnostic ultrasound systems around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

About NeuroLogica Corp.

NeuroLogica, the healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. NeuroLogica, the global corporate headquarters and manufacturer of mobile computed tomography, is also the US headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. NeuroLogica’s growing portfolio of advanced medical technologies is used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. For more information, please visit http://www.NeuroLogica.com.

* Content has been updated as of February 10, 2023 to more accurately reflect product information.

¹ ALND cannot be used on patients who have lung lesions other than abnormal nodules.

² Y. Sim et al, Deep Convolutional Neural Network-based Software Improves Radiologist Detection of Malignant Lung Nodules on Chest Radiographs. Radiology, 2020

Samsung Electronics, a leader in medical imaging technology, is showcasing its latest Ultrasound, Digital Radiography, Computed Tomography (CT), Magnetic Resonance Imaging (MRI) concept and their software innovations at the Radiological Society of North America (RSNA) 2018 Annual Meeting at McCormick Place in Chicago.

“We are pleased that Samsung’s AI technologies have been successfully applied to the existing diagnostic imaging devices and have been well received in the market,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “As a comprehensive diagnostic imaging solution provider, we will continue to strengthen our technologies through collaboration with hospitals and healthcare professionals. We aim to bring together radiologists and AI to fill in the gaps for improved healthcare management.”

Samsung showcases several types of AI based diagnostic imaging software:

• Ultrasound System – S-Detect for Breast is AI based software which analyzes breast lesions using ultrasound images, and has been implemented into Samsung’s ultrasound systems dedicated to Radiology. It assists in standardizing reports and classification of suspicious breast lesions by incorporating BIRADS® ATLAS* (Breast Imaging-Reporting and Data System, Atlas)

According to a recently published study¹ by radiology professor Tommaso Bartolotta from the University of Palermo in Italy, S-Detect for Breast has shown to assist various degrees of improvement in the overall diagnosis of breast lesions. When using S-Detect for Breast, the diagnostic accuracy for doctors with experience of four years or less improved from 0.83 to 0.87 (AUC, Area Under Curve). S-Detect for Breast could be a useful tool for supporting and guiding breast diagnosis among non-expert breast imaging physicians (Only shape and orientation descriptors are automatically classified in the United States).

• Digital Radiography – By using AI technology, the ‘Bone Suppression’ function, which reduces the bone signal from the chest x-ray image, clearly brings out the lung tissues obscured by the bones. ‘SimGrid’ has also been introduced as a solution to ease the workflow to replace grids, while providing excellent image quality with reduced scatter artifacts. According to a recently published study², ‘SimGrid’ provided image quality almost as good as the images taken with a physical grid.

The Auto Lung Nodule Detection (ALND) is a CAD (Computer Aided Detection) solution based on AI technology used in the detection of lung nodules and is 510(k) pending. According to a recent  study³in press in Journal of Thoracic Imaging, ALND improved the detection sensitivity of lung cancer nodules 3 cm or smaller in chest radiographs by seven percentage points to 92 percent, compared with the average of six chest radiologists.

• Computed Tomography – Samsung has introduced the intra-cranial hemorrhage package that combines a mobile stroke unit with a radiological computer aided triage and notification solution based on AI technology.

• Magnetic Resonance Imaging – Utilizing AI technology, Samsung is developing a technology to display information such as knee cartilage thickness as well as images of knee arthritis patients. The software is a prototype and not for sale in any region of the world.

At the Samsung booth, attendees will find a separate ‘AI zone’ that allows visitors to experience Samsung’s AI technology more easily. Samsung will also host a symposium that will demonstrate how its image processing technology improves diagnostic accuracy and promote radiation safety for pediatric patients.

Through the release of new diagnostic tools that utilize diverse data based on AI technology, Samsung will continue to support healthcare professionals to improve the diagnostic accuracy.

For more information on Samsung’s healthcare business, and products, please visit https://www.samsunghealthcare.com.

About Samsung Medison

Samsung Medison is a global leading medical device company, founded in 1985. With a mission to bring health and well-being of people’s lives, the company manufactures diagnostic ultrasound systems around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

¹Tommaso Vincenzo Bartolotta, et al. Focal breast lesion characterization according to the BIRADS US lexicon: role of a computer aided decision making support. La radiologia medica. 2018 Mar 22

²S. Y. Ahn, et al. The Potential Role of Grid-Like Software in Bedside Chest Radiography in Improving Image Quality and Dose Reduction: An Observer Preference Study. Korean J Radiol, 2018; 19(3):526-533

³M.J. Cha, et al. Performance of Deep Learning Model in Detecting Operable Lung Cancer with Chest Radiographs. J Thorac Imaging, 2018 In press

Visitors to Samsung Electronics’ booth at the Radiological Society of North America’s (RSNA) 2016 annual meeting in Chicago examine the GM85 mobile digital radiography (DR) system.

Samsung Electronics showcases the GM85 Digital Radiography (DR) system which received 510(k) FDA clearance November 17 for the US market, at the Radiological Society of North America (RSNA) 2016 Annual Meeting at McCormick Place in Chicago. At RSNA booth #4735 (South Building, Hall A), Samsung demonstrates the ultimate driving experience for radiologists and technicians by offering the “GM85 Driving Event”.

“Celebrating our fifth year participating at RSNA, the largest radiology meeting, we would like to thank our valued customers and partners for their ongoing trust and support of our medical imaging innovations,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “Listening to our customers’ needs and acting swiftly to fulfill them has led to Samsung’s fast growth in radiology.”

Visitors to Samsung Electronics’ booth at the Radiological Society of North America’s (RSNA) 2016 annual meeting in Chicago examine the GM85 mobile digital radiography (DR) system.

Along with the GM85, Samsung will showcase a wide range of medical imaging solutions from premium mobile digital X-ray to advanced ultrasound systems. Moreover, new clinical research showing how Samsung’s latest ultrasound technology drives better patient care will be presented at its RSNA Corporate Symposium session Monday 8:30 a.m. – 10:00 a.m. in Room S101AB. Register to attend here.

“Our products continue to prove their versatility as more healthcare providers find new innovative ways to use them,” said Philip Sullivan, Samsung NeuroLogica President and CEO. “RSNA is a great venue for radiologists to learn the diverse ways we are helping hospitals, clinicians and patients.”

Visitors were also given a chance to experience the mobile DR system for themselves.

On display at Samsung’s booth are the following technologies:

Digital Radiography (DR)

GM85 [FDA 510(k) cleared November 17, 2016]

• Easy Navigating with Compact Design: With 555mm narrow width and weighing in at a light 349kg, the GM85 allows easy access around tight spaces, even in elevators. A collapsible column gives users clear visibility when moving the system and broadens access to smaller spaces. Adaptive soft-driving control and front-bumper sensor also help make navigation safer.
• Optimized Workflow with Enhanced Usability: SID (Source to Image Distance) Guide supports detailed device positioning with multiple SID settings. S-Align displays the detector’s angle to the THU (Tube Head Unit) for precise alignment to enhance image quality. Quick-positioning allows handle-free, precise body movement by simple button clicks on the THU and optimizes workflow, enabling users to save time.
• Advanced Imaging Technology for Superior Image Quality: S-Vue, the advanced imaging engine, enhances image sharpness and clarity. SimGrid provides high-quality images without using a conventional grid, reducing scatter radiation effects. Also, radiographers can lower retake rates as S-Vue eliminates alignment errors that often occur with a conventional grid.

GC85A (Advanced Applications) adds new features to radiography workflows:

• Fast Stitching: Our upgraded stitching technology reduces process time by 31% compared to the original GC85A. Increased process speed means radiographers receive exam images more quickly. Fast stitching helps lessen the burden on patients who find it difficult to stand for an extended period of time and leave the x-ray room faster than before.
• SimGrid: This feature streamlines workflow because it operates without a portable grid, reducing operator wrist overload. SimGrid also eliminates alignment errors that often occur with portable grids, reducing retake rates and increasing patient satisfaction.
• Bone Suppression: Clarity of soft tissue is improved when suppressing the appearance of bones in chest images.

The booth showcased 8 examples of the GM85 mobile digital radiography (DR) system for users’ examination.

Portable Computed Tomography (CT)

The BodyTom and CereTom portable systems continue to prove their versatility as they are increasingly adopted and utilized in a wide range of market applications such as mobile stroke units, brachytherapy suites and proton therapy centers, deep brain stimulation and even veterinarian hospitals.

CereTom receives accolades as more mobile stroke treatment units implement the CT scanner:

• The use of CereTom-equipped mobile stroke units expands to several new cities, including New York City, Chicago, and Trenton, New Jersey
• CereTom was awarded a showcase spot among 14 medical innovations before thousands of hospital executives at Premier Inc.’s Annual Innovation Celebration during the company’s 2016 Breakthroughs Conference and Exhibition June 21 for healthcare providers.

BodyTom expands into new care paths as radiologists find more value:

• The University of Texas MD Anderson Cancer Center in Houston, Texas added BodyTom® CT, the world’s first portable, full-body, 32-slice CT (computed tomography) scanner to its Proton Therapy Center and is now treating patients at the facility using images from the scanner.
• The University of Wisconsin (UW) Carbone Cancer Center in Madison recently incorporated BodyTom® technology into its radiation oncology brachytherapy planning process.
• Willis-Knighton Cancer Center in Shreveport, La., also added BodyTom® CT to its brachytherapy suite.

The booth also included an ambulance equipped with Samsung Electronics’ acclaimed CereTom portable computed tomography (CT) scanner – a versatile system utilized in mobile stroke units and a range of other emergency applications.

Ultrasound

RS80A with Prestige – live scanning demos at our RSNA booth – offers cutting-edge features:

• CEUS+: On the heels of the recent FDA approval of contrast-enhanced ultrasound for liver lesions in adults and pediatrics, Samsung introduces its latest contrast-enhanced ultrasound imaging, CEUS+. The RS80A premium ultrasound system applying sophisticated imaging technology that empowers user’s confident diagnosis. The superb resolution and improved uniformity help users acquire better clarity in the near field. Its automatic brightness-control feature optimizes imaging in real-time, providing users with enough time to diagnose. The CEUS+ also improves the diagnosis of small lesions, and its clear expression of tissue boundaries helps users to achieve interventional procedures with ease and accuracy.
• S-Detect^TM for Breast [pending FDA 510(k) clearance, not yet available in the U.S.] – Applying data from 10,000 breast exams to ultrasound imaging, S-Detect helps radiologists understand characteristics of breast lesions to determine whether they’re malignant or benign in a few clicks. The S-Detect^TM provides faster and more accurate results by adopting a big-data, deep-learning algorithm in lesion segmentation, characteristic analysis and assessment processes.

A Samsung representative explains the intricacies of the contrast-enhanced CEUS+ ultrasound imaging system, which provides clear and uniform images for more accurate diagnoses.

For more information on Samsung’s global medical imaging technologies, please visit www.samsungmedicalsolution.com. At RSNA visit booth #4735 (South Building, Hall A) and stay up-to-date by following the Samsung NeuroLogica Twitter feed @SamsungHealthUS.

About NeuroLogica

NeuroLogica, the healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. NeuroLogica, the global corporate headquarters and manufacturer of computed tomography, is also the U.S. headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. NeuroLogica’s growing portfolio of advanced medical technologies are used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. Samsung is committed to being leaders in the field of healthcare imaging. For more information, please visit http://www.SamsungNeuroLogica.com.

Samsung Electronics will be participating in this year’s Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), the world’s largest radiology conference, to unveil its latest innovations and contributions in healthcare.

Come visit us at Chicago’s McCormick Place (South Hall A: #4735) from November 27 to December 2.

For the latest information about Samsung’s healthcare events, please follow the link below:

http://samsungmedicalsolution.com/en/common/eventViewList

For a sneak peek into our latest radiology product please follow the link below:

http://gm85.samsungmedicalsolution.com/

Visitors awaiting Samsung Electronics’ CT unveiling at the RSNA’s 101st annual meeting on November 28.

Samsung Electronics is strengthening its commitment to delivering fast, reliable, smart and innovative diagnostic solutions for healthcare providers by debuting the newest additions to its portfolio, on display at the Radiological Society of North America (RSNA) Annual Meeting at McCormick Place in Chicago. This week at booth #7313 (North Building, Hall B), product specialists will be on hand demonstrating Samsung’s range of solutions in Computed Tomography (CT), Ultrasound and Digital Radiography (DR) systems, which are all designed to enrich the quality of care and workflow, and enhance the patient experience.

“Through our innovative designs and advanced technologies, we remain committed to delivering new solutions, like the NExCT 7 and the RS80A with Prestige, that unlock workflow efficiencies for medical professionals as well as improve patients’ lives,” said Soo-In Cho, President and Head of the Health & Medical Equipment Business at Samsung Electronics Co., Ltd. “By leveraging the combination of Samsung imaging technology and user-inspired design, we will continue to deliver on our promise of fast, easy and accurate diagnostic solutions for our customers in the healthcare community.”

Wayne Spittle, Executive Vice President of Samsung Medison, introducing the NExCT 7, Samsung’s first CT scanner.

Computed Tomography (CT) Segment

Samsung’s CT imaging solutions are used throughout the world in intensive care units, neurosurgical operating rooms, emergency departments, stroke centers and other key clinical areas. Debuting at RSNA is:

• NExCT 7 – the first premium CT scanner from Samsung features high resolution designed to improve diagnostic confidence in advanced and routine exams reducing the radiation dose as low as reasonably achievable and ensuring a fast and efficient workflow. Some features of the NExCT7 are FDA 510(k) pending.

• Portable CT – Samsung will be showcasing the latest in software and hardware enhancements across its portable CT product line. These upgrades improve user satisfaction and streamline workflow, and both systems are now compliant with the Smart Dose (XR-29) radiation dose reporting standard.

The BodyTom and CereTom portable systems continue to prove their versatility as they are increasingly adopted and utilized in a wide range of market applications such as mobile stroke units, brachytherapy suites, proton therapy centers, deep brain stimulation and even veterinarian hospitals.

Ultrasound Segment

Samsung continues to enhance the user experience with its cutting-edge diagnostic ultrasound devices around the world and across various medical fields. On display at RSNA are:

• RS80A with Prestige – now available in the U.S. market, this system features advanced technical capabilities built on the successes of Samsung technologies. Product features include:

• S-Fusion to enable simultaneous localization of lesions with a real-time ultrasound image supported by other modalities’ 3D data sets. Fusion speed and accuracy are the strengths of S-Fusion.
• S-Shearwave to detect the velocity of the shearwave transmitted through the targeted lesion and display the numerical measurement of stiffness.
• E-Breast*: this is the function for breast lesion exam, which calculates the strain between the area of the suspected lesion (ROI) and normal breast fat and displays the results.
• E-Thyroid*: This function assists with the diagnosis of thyroid lesions. The ROI is used to show the contrast of an elastogram.*The strain ratio value is a relative value regarding quantification, not an absolute value.

• HS70A – designed for hospital and private care. This system has a flexible architecture to meet the clinical needs of varied users. The HS70A offers a complete Radiology and Cardiovascular solution, including technologies migrated from the premium radiology RS80A platform. Features include S-Detect, which uses Breast Imaging-Reporting, and Data System (BI-RADS®) scores for analysis and classification of suspicious lesions.

Digital Radiography (DR) Segment

Samsung’s DR systems combine advanced imaging technology, award-winning design and user-friendly automated workflows to meet the demands of 21st century radiology departments. Products on display at RSNA include:

• GC85A – a DR system offering streamlined workflow, diagnostic confidence and improved total cost of ownership. The GC85A features imaging engine S-Vue, ensuring consistency with high quality, convenient setting of contrast and improved sharpness and clarity, S-Share to support unique clinical needs and continuous care with increased connectivity, and Smart Control for one-touch precise positioning.
• GM60A – a mobile Digital Radiography system that delivers high-quality imaging directly to the patient’s bedside. Advanced mobility allows use in the patient room, emergency room, operating room and the intensive care unit, and has advanced features, including S-Detector and S-Vue imaging technologies to deliver accurate diagnoses while ensuring reliable operation with enhanced usability. Additionally, the telescopic column ensures fast navigation by securing a clear view for users.

For more information about Samsung’s showcase at RSNA, please visit http://www.samsung.com/rsna2015.

To learn more about Samsung’s healthcare work, please visit samsung.com/global/business/healthcare/.

About NeuroLogica

NeuroLogica, a healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. NeuroLogica, the global corporate headquarters and manufacturer of computed tomography, is also the U.S. headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. NeuroLogica’s growing portfolio of advanced medical technologies are used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. Samsung is committed to being leaders in the field of healthcare imaging. For more information, please visit www.SamsungNeuroLogica.com.